Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
Sun Pharma Shares Soar After ₹3,000 Crore Acquisition Of US-Based Biotech Company
Sun Pharma shares rose like the sun in the intraday trade on Tuesday, as the company shares surged by over 2 per cent in the ...
moneycontrol.com7d
Sun Pharma shares rise over 3% with positive brokerage outlook as firm to acquire US biotech company
Sun Pharmaceutical Industries Limited shares gained over 3 percent on Tuesday, March 11, after ICICI Securities' upgrade on rating the stock to 'Buy'. This adds to the continued positive investor ...
India's Sun Pharma buys onco-derma firm Checkpoint Therapeutics for $355M
India's pharma giant Sun Pharma is to acquire Checkpoint Therapeutics (NASDAQ:CKPT)—an immunotherapy and targeted ...
Reuters9d
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million
March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...